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Somatic mutation ofIg variable genes occurs byaunique mechanism that creates
diversityinantibodies afterantigen stimulation. Mutationischaracterizedby a high
frequency ofnucleotide substitutions within alocalized region surrounding the rear-
ranged variable gene (1, 2). To date, the mechanism ofmutation is not well under-
stood. Progress has been hampered by the lack of experimental systems to study
mutation, in that most B cell lines do not mutate in vitro, nor is it known when
B cells mutate in vivo. Previous work has indicated that mutation appears in anti-
bodyvariable genes2 wkafterprimary immunization ofmice (3), but it isnotknown
when the process begins. As a first step towards understanding the mechanism of
somatic mutation, we have studied the dynamics of mutation in vivo in order to
define a population of B cells undergoing mutation for future studies.
Preliminaryexperiments demonstrated that severalantibody specificitieswere pro-
duced in response to a primary injection of phosphorylcholine (PC)' conjugated
to aprotein carrier with Bordetellapertussis adjuvant. RIAs of supernatants from hy-
bridomas made 1-2 wk after immunization showed that 6% were specific for PC,
14% werespecific for thecarrier, and30% were specific fortheadjuvant. The specificity
ofthe other 50% was unknown but may have included the constant region of self-
IgG (4) and other autoantigens, or the hybridomas may have been derived from
nonspecificallyactivated B cells. Nucleotide sequence analysis showed that the PC-
specific antibodies were encoded by the VV1 gene segment of the VHS107 sub-
family, and the other antibodies were encoded by various gene segments from the
V7183, VH3660, and VKJ558 subfamilies. Gene segments from three of the sub-
families, V7183, VH3660, and VS107, were further analyzed because many oftheir
germline sequenceswere publishedand couldbe usedto identifymutatedsequences.
An experimental approach to identify mutation was used that is more rapid and
efficientthan preparinghybridomas. Splenic mRNA from immunized mice was an-
nealed to y constant region primers to make cDNA transcripts encoding VH genes,
and the cDNA clones were sequenced. Only transcripts from IgG-producing B cells
were studied since mutation is found more frequently in IgG antibodies than in
This work was supportedby National Institutes of Health grant CA-34127 andAmerican Cancer So-
ciety grant IM491.
'Abbreviations used in this paper . FWR, framework regions; HVR, hypervariable regions; KLH, key-
hole limpet hemocyanin; PC, phosphorylcholine; R, replacement; S, silent.
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IgM antibodies (5). The results showed that V genes had a low level of mutation
by day 5 after immunization and accumulated more mutation by day 7 at a rate
of 10-3 mutations per nucleotide per generation. However, by day 13, the number
of mutations per gene did not increase, and mutations were found clustered in the
hypervariable regions. We conclude that mutations were generated mainly during
the first week ofthe immune response and were selected for binding to antigen during
the second week.
Materials and Methods
Immunization.
￿
BALB/cJ males 8 wks old (TheJackson Laboratory, Bar Harbor, ME) were
immunized with 100 hg i.p. of alum-precipitated PC-keyhole limpet hemocyanin (KLH)
(generously provided by J . Kenny, Frederick Cancer Research Facility, Frederick, MD) and
109 heat-killed Bordetella pertussis (Calbiochem, LaJolla, CA). Mice were killed 5, 7, and 13 d
after immunization. The number of mice used on each day was 12, 14, and 4, respectively.
Preparation ofRNA.
￿
All of the spleens from each time point were pooled to make one cDNA
library, with the exception of day 7 when one cDNA library was made from two mice and
a second cDNA library was made from 12 mice. Spleens were removed, frozen immediately
in liquid N2, and crushed into a fine powder while suspended in liquid N2. The suspension
was transferred to a 50-ml conical tube at 4°C and then resuspended in 12 .5 ml/spleen of
4 M guanidine thiocyanate (Fluka Chemical Corp., Ronkonkoma, NY), 0.5% sarkosyl, 25
mM sodium citrate, pH 7, and 0.1 M (3-mercaptoethanol (6). The mixture was homogenized
extensively and then vortexed at high speed for 30 s. 25 ml of homogenate was layered onto
a 10-ml cushion of 5.7 M cesium chloride, 0.1 M EDTA, pH 7, in a polyallomer SW27 tube
and spun at 26,500 rpm for 30 h at 15°C. The supernatant was discarded and the RNA pellet
was solubilized in 180 wl of guanidine thiocyanate without sarkosyl and precipitated in 0.2 M
potassium acetate and 2 vol of ethanol. The RNA pellet was resuspended in 1°Io sarkosyl,
20 mM EDTA, pH 7, extracted with phenol and phenol:chloroform 1 :1, and precipitated
with ethanol. Poly(A)' RNA was obtained by chromatography over an oligo-dT-cellulose
column (Collaborative Research, Lexington, MA).
cDNA Library Construction, Screening, and Sequencing.
￿
cDNA was made according to a cDNA
synthesis System Plus (code RPN 1256; Amersham Corp., Arlington Heights, IL) using Eco
RI linkers. The cDNA was size selected on a 4% polyacrylamide gel, and molecules in the
400-600-bp range were electroeluted and cloned into the Eco RI site of the Xgt10 vector.
Constant region primers complementary to the 5' end of yl, -y2a, -y2b, y3, and C,, regions
were used to initiate synthesis. The C primer was included to increase recovery of cDNA.
cDNA libraries were screened separately with the following probes: a 210-bp Eco RI-Pst I
fragment encoding the V81X gene from the V7183 subfamily (7); a 635-bp Xba I-Eco RI
fragment encoding the VSB32 gene from the V3660 subfamily (8); and a 450-bp Hind
III-Bam HI fragment encoding a cDNA copy of VVl from the VS107 subfamily rear-
ranged to DFL16.1 andJ1. Filters were washed at high stringency (9). Positive plaques were
isolated and cDNA inserts were subcloned into M13 vectors for sequence analysis by the dideoxy
chain termination method. Approximately 10 cDNA clones from each subfamily were se-
quenced at each time point.
Assignment ofMutations.
￿
Mutations were identified by comparing each sequence to germ-
line or consensus sequences known for that subfamily. 13 of the 20 gene segments known
for the V7183 subfamily were identified among our cDNA clones (Fig. 1), and seven were
not found: V,MOPC21 (7), V81X (7), VE4.PSI (7), V,E4.15 (7), 36CON (15), V37.1 (16),
and V50.1 (16). For the V3660 subfamily, four of the five known gene segments were
identified among the cDNA clones (Fig. 1), and one was not found: V1210 (17). V1B43 of
the V3660 subfamily i$ identical to VVGam3-2 (18) with the exception of a T to C change
at position II of amino acid 28. Since we have sequenced this gene twice with the same substi-
tution, VVGam3-2 may contain a mutation at this site. For the VS107 subfamily, one of
the four germline gene segments (12), VVl, was used, and three were not found: VV3,
VVll, and VV13. D and J sequences were assigned to known germline-encoded gene seg-~"a°,
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ments. However, variability at the site of joining of V, D, and J gene segments could be
due to N regions or mutations. As a general rule, base differences at these junctions were
called mutations only when they were locatedthree or more nucleotides into germline-encoded
gene segments. When determining whetherbase changes were silent or replacement muta-
tions, twochangesoccurringin thesame codonwere countedindependently, and silent changes
were considered to have occurred first.
Results
Sequences of V  Genes.
￿
Mutations were identified by comparing V sequences from
sequential time points afterimmunization to known germline or consensus sequences.
The 18 V  gene segments found in this study included both previously published
and new sequences (Fig; 1). In the V 7183 subfamily, eight gene segments were pre-
viously identified and five are new. The new gene segments have >85% nucleotide
homology to other members of the subfamily. Of the five new gene segments,
V,345, V H914, and V5-84 were found repeatedly in independent rearrangements,
and V,5-76 and V 7-39 were found only once. The latter two sequences have 17
and 13 differences respectively from the nearest homologous gene segments, VV2
and V 37.1. Because the number of differences exceeds the highest reported fre-
quency of mutation in VH gene segments (4%, reference 2), it is likely that these
are new V, gene segments that may contain mutations. Both V5-76 and V7-39
sequences are included in Fig. 1, butwere notused to calculate mutation frequency.
In the V H3660 subfamily, three gene segments were previously identified and one,
V733, is new. V733 has >85% homology to other members of the subfamily, but
is unique in that it has three extra bases coding for amino acid 35B and does not
have an Eco RI site at amino acid 82 . In the V.S107 subfamily, the VV1 gene seg-
ment was exclusively used. An unusual hybrid gene, clone 5-1 of the V.S107 sub-
family (Table I), was isolated that contained sequences from V RF of the V 7183
subfamily and VVl of the V.S107 subfamily; the origin of this clone will be dis-
cussed in a separate paper (Levy, N., and P. Gearhart, manuscript in preparation).
The gene segments encoding 103 cDNA clones from immunized mice are sum-
marized in Table I. Some clones were encoded by certain combinations of gene seg-
ments, which suggests they encode an antibody specific for a single determinant.
For example, the vast majority of clones in the V.S107 subfamily were encoded by
V Vl, DFL16.1, andJ.1 gene segments, which is characteristic of antibodies specific
for PC (19), and many clones from the V H3660 subfamily used a combination of
V H733, DQ52, andJH2 gene segments. Other clones used a variety of gene segments
and may be derived from antigen-stimulated or nonspecifically activated B cells.
Time Course ofMutation.
￿
Mutations were scored 5, 7, and 13 d after primary im-
munization. The position, number, and type of mutation in each cDNA clone are
shown in Fig. 2 and Table II. All of the mutationswere single or double nucleotide
substitutions; no insertions or deletions were observed. V genes from all three sub-
families showed a similar increase in mutation frequency over time. As seen in Fig.
3, the frequency was lowest on day 5, increased more than twofold on day 7, and
slightly increased on day 13. An exception to this pattern were the clones in the
V .S107 subfamily, which decreased in mutation frequency on day 13 .
To ascertain whethermutation occurred sequentially on a gene after cell division,
we determined the number of mutations per gene over time. Many VH sequencesLEVY ET AL.
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TABLE I
Description of Gene Segments Encoding cDMA Clones
SP2 in the D column signifies the sequence was too short to be uniquely identified. The SP2.9 sequence
is reported in reference 13. All of the gene segments were productivelyjoined to encode heavy chain proteins.
Sequence was too short to assign to either the -yl or -y2 constant gene.
1 M315, SB32, and 1B43 VH gene segments had an Eco RI site at amino acid 82 which prevented recovery
of the D and JH gene segments. Clone 3660-28 contained a mutation that removed the Eco RI site.
VH Day 5 Day 7 Day 13
subfamily Clone VH D JH IgG Clone VH D JH IgG Clone VH D JH IgG
7183 76 5-76 SP2.2 4 2b 11 V3 FL16.1 4 2a 16 283 FL16 3 2a
77 RF Q52 4 26 12 345 SP2.9 4 2a 17 345 Q52 4 3
78 345 SP2 1 26 13 V2 SP2.3 4 2 18 V2 FL16 .2 4 1,2'
79 RF Q52 1 2b 14 V4 SP2 4 2b 21 914 FL16.1 2 1
80 RF SP2.2 1 2b 15 76 SP2.2 4 2b 23 RF FL16.1 4 1
81A 283 FL16.1 3 2b 36 283 SP2 1 26 25 345 FL16.1 4 1,2"
81B 14.29 SP2.2 2 2b 37 345 SP2 4 3 26 345 SP2.2 4 2a
82 5-84 SP2 1 2a 38 V2 FL16.2 4 2b 29 345 SP2 4 1,2'
83 345 SP2.2 2 2a 39 7-39 Q52 4 2b 30 345 Q52 4 26
84 5-84 SP2 4 '3 44A 914 SP2.2 3 1 33 6.96 SP2 4 2a
85 345 SP2.9 4 3 44B 283 SP2.2 1 3 34 RF SP2.2 4 1
F7 914 SP2 1 26 45 345 FL16.1 2 2b 35 345 SP2 4 1,2'
F9 345 FL16.2 1 3 13-2 345 SP2.6 1 2a
13-4 283 SP2.9 1 26
13-20 6.96 SP2.9 1 2a
3660$ 68 M315 11 SB32 20 SB32
70 733 Q52 1 26 12 M315 23 SB32
75 SB32 28 M315 Q52 4 3 24 1B43
76 733 Q52 2 3 30 SB32 25 M315
32 SB32 27 IB43
33 733 Q52 2 1
35 733 Q52 2 3
36 733 Q52 2 3
37 733 Q52 2 3
S107 5-1 RFN1 FL16.1 1 1 7-1 V1 FL16.1 1 1 13-3 V1 FL16.1 1 2b
5-3 V1 FL16.1 1 2a 7-2 V1 FL16.1 1 1 13-4 V1 FL16.1 1 1,2'
5-4 Vl FL16.1 3 2b 7-3 V1 FL16.1 1 2b 13-5 V1 FL16.1 1 3
5-5 V1 FL16.1 1 3 7-4 V1 FL16.1 1 1 13-7 V1 FL16.1 1 2b
5-6 V1 FL16.1 1 2b 7-5 V1 FL16.1 1 3 13-13 V1 FL16.2 1 1
5-7 V 1 SP2 1 3 7-6 V1 FL16.1 1 1 13-16 V1 FL16.1 1 3
5-8 V1 FL16.1 1 1 7-7 V1 FL16.1 1 1 13-18 V1 FL16.1 1 2a
5-9 V1 FL16.1 1 3 7-9 V1 FL16.1 1 3 13-22 V1 FL16.1 1 1
5-10 V1 FL16.1 1 3 7-10 V1 FL16.1 1 3 13-26 V1 FL16.1 1 1
7-11 V1 SP2.2 1 3 13-32 V1 FL16.1 1 1
7-11A V1 FL16.1 1 1 13-33 V1 FL16.1 1 3
7-12 V1 FL16.1 1 3 13-34 V1 SP2.2 1 3
7-13 V1 FL16.1 1 3 13-35 V1 FL16.1 1 1
7-14 V1 FL16.1 1 2a 13-36 V1 FL16.1 1 3
7-15 V1 FL16.1 1 1 13-40 V1 FL16.1 1 1,2`
7-17 V1 FL16.1 1 1 13-42 V1 FL16.1 1 1,2'
7-18 V1 FL16.1 1 3
7-19 V1 FL16.1 1 3
7-20 V1 FL16.1 1 22012 ONSET OF SOMATIC MUTATION IN IMMUNOGLOBULIN V GENES
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FIGURE 2.
￿
Schematic representation of mutations found in cDNA variable regions after pri-
mary immunization with PC-KLH. Horizontal lines show the extent of sequencing relative to
the aminoacid (a.a.) codons of the correspondingV genes(see Table I). Vertical bars show the
relative position of codons containing nucleotide differences. A black circle on top of the bar
represents areplacement mutation andno circle indicates a silent mutation. Parentheses indicate
that no germline sequence was found for the clone.
did not contain anymutations, suggesting that not all B cells had undergone muta-
tion. Indeed, statistical analysis showed that the number ofmutations per clone on
day 7 did not fit a Poisson distribution expected for mutation occurring randomly
in all B cells (fib < 0.01); rather, only a portionofthe B cells appeared to be mutating.
To calculate the number ofmutations per gene, only those clones with at least one
mutation were considered. The number ofmutations found on each day wasdivided
by the numberofnucleotides sequenced and multiplied by 350 bp, which is the av-
eragelength ofa rearranged V, gene. This analysis showed that the number ofmu-
tations per gene increased from 2.0 on day 5 to 3.4 on day 7, and decreased to 3.0
on day 13. A mutation rate of0.3 x 10-3 was calculated between days 5 and 7 based
on the increase in unselected, silent mutations and a generation time of 18 h. As-
suming the silent changes represented one-third oftotal mutations, the overall rate
of mutation was _10-3 mutations/nucleotide/generation, which is consistent with
the rate calculated by others (15, 20, 21).TABLE II
Summary of Mutations in cDNA Clones
VH sub-
￿
Amino Base Position
￿
VH sub-
￿
Amino Base Position
Day family Clone acid change in codon Type' Day family Clone acid change in codon Type"
Replacement (R) or silent (S) mutation.
$ Mutation shared by clones 7-1, 7-2, 7-6, 7-7, and 7-17 of the S107 subfamily.
5 Mutation shared by clones 7-2 and 7-17 of the S107 subfamily.
II Mutation shared by clones 7-6 and 7-7 of the S107 subfamily.
5 7183 76 100C G-A I R 13 7183 16 - 17 T-C I R
102 A-C II R 99 G-A II R
78 27 T-+C II R 17 50 T-"A I R
81A 85 G-A III S C-.A II R
F7 31 G-+A II R 52A A-G I R
56 C-T III S 76 A-C II R
57 C-T II R 79 T-.A I R
C-+T III S 89 G-C III R
81 A-T II R 102 T-.C I R
3660 76 - 9 T-"G I R 21 13 A-"G II R
7 7183 14 31 G-+C II R 53 G-"A I R
C-+T III S 56 A-C I R
52A A-+G I R 78 G-A III S
55 G-+C II R 110 A-G I R
60 C-A II R 29 52 G-A II R
75 A-"G II R 30 50 A-.C II R
100 C-G II R 52 G-+A II R
15 82A A-G I R 56 A-T I R
86 C-T III S G-C II R
10017 G-C I R 89 G-C III R
36 2 G-A I R 33 31 C-T III S
G-A III S 32 A-T II R
3 G-+A III R 55 G-A II R
4 G-+A III S 98 G-A I R
93 G-A I R T-+G III S
38 34 G-+A III R 35 30 T-+C III S
56 C-.T III S 40 C-A II R
69 C-+A III S l00B A-T I R
44B 79 A-.T II R 112 C-+T III S
3660 28 34 T-.C I R 13-20 82A C-+T III S
37 A-T I R 3660 20 59 T-C I R
43 A-G II R 64 A-G II R
74 T-.G III S 24 58 G-+A II R
81 G-C III R 25 37 A-~G I R
83 A-"G II R 52 A-G I R
88 T-.C III S G-A II R
100A C-.A I R 56 G-A II R
102 C-"T I R 27 56 A-G II R
33 21 A-G I R 58 G-A II R
108 C-.A II R S107 13-3 93 C-T II R
109 C-T I R 13-4 17 T-+C III S
5107 7-1 - 3 A-C I R
52CI G-C I R
1001 G-+A II R
1011 G-A II R
7-2 64§ A-G II R
74 A-.G III S
80 G-C III R
7-6 511 G-A III S
2811 C-"G III S
7-7 32 T-C II R
7-10 82B C-T II R2014
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Distribution ofMutations in the Hypervariable Regions (HVR) and Framework Regions
(FWR). To determine if mutations had been selected for binding to antigen, we
analyzed the distribution of mutations within the variable region. Since the HVR
encode antigen-binding sites, one wouldexpect that mutants selected forhigher affinity
would have both a higher number of mutations and more replacement (R) than
silent (S) mutations in the HVR than expected for a random distribution. Alterna-
tively, in the FWR where structure needs to be conserved to maintain function, one
would expect to find a lower number ofmutations and fewer R substitutions than
expected under random conditions. As shown in Table III, this is indeed the case,
in that the proportion ofmutations and the ratio of R to S increased in the HVR
between days 7 and 13. Theresultsindicate that some selection forhigh affinity anti-
bodies had occurred by day 7 and was more pronounced by day 13.
Transitions and Tansversions.
￿
The types of nucleotide substitutions may provide
information concerning the mechanism of somatic mutation. Onlythe silent muta-
tions were analyzed because they are not selected at the protein level. Mutations
were recorded fromthe sensestrand ofDNA such that aC->T substitution indicates
that a C:G pair was replaced by a T:A pair; however, the mutation may have taken
place on either strand. Out of 21 silent mutations, 17 were transitions, including
eight C-T, five G-A, three T-C, and one A-G. Transversion base changes in-
cluded two T-G, one C-G, and one C-A.
Clonal Relationship.
￿
The presence ofV, genes with identical mutations suggests
that the original precursor may have been a secondary B cell. Five cDNA clones
TABLE III
Increased Selection of Mutations with Time
* Random percentages were calculated based on length of region. Experimen-
tal data consist of 40 mutations for day 7, and 42 mutations for day 13 .
$ Random ratios were calculated based on the codons used by genes in this study.
The number of substitutions found on days 7 and 13 is shown in parentheses.
Percent
HVR
mutations*
FWR
R/S
HVR
ratiol
FWR
Random 20 80 3.9 3 .1
Day 7 40 60 7 .5 (15:2) 1 .8 (16:9)
Day 13 65 35 12 .0 (24:2) 1 .8 (9:5)LEVY ET AL.
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from the V S107 subfamily on day 7 appeared to be derived from the same
precursor because they shared the same V,-D and DJH junctions and three muta-
tions in the V, and D gene segments. In addition to the shared mutations, each
clone had unique mutations. A genealogical tree can be constructed to describe the
relationship between these cDNA clones. The initial events included three muta-
tions at amino acids 52C, 100, and 101. Although a cDNA containing these three
mutations was not found, it is the logical progenitor of the later members of this
tree. After cell division, four new mutations at amino acids -3, 5, 28, and 32 oc-
curred among three daughter cells, giving rise to clones 1, 6, and 17. After further
cell division, another three mutations at amino acids 64, 74, and 80 occurred in
clones 6 and 17, giving rise to daughter cells 7 and 2, respectively.
Discussion
Mutation Appears EarlyafterImmunization.
￿
We have determined theonsetof muta-
tion in vivo in order to define a population of cells actively undergoing mutation.
To date, studies focusing on the primary immune response have reported a high
frequency of mutation in hybridomas made 14 d after immunization, but little or
no mutation after 3-9 d (22-24). However, our results of sequences from cDNA
clones of splenic mRNA show that the mutational mechanism is activated as early
as day 5 after primary immunization and continues through day 7, giving rise to
an increase in both the frequencyand number ofmutations pergene. Thehigh level
of mutation on day 7 was observed in two independently generated cDNA libraries
and is unlikely to be an artifact. One reason for the discrepancy between our data
and previous reports may be that cells undergoing mutation are refractory to cell
fusion and would not be detected as hybridomas.
An analysis ofthe generation of mutation must take into account thecontribution
of secondary, IgG-producing B cells. Secondary B cells mayhave accumulated mu-
tation before immunization with PC-KLH, and thedata would not represent newly
occurring mutation. Alternatively, some or all of the mutations may have occurred
after restimulation of secondary B cells. In our data five cDNA clones were found
from the V S107 subfamily on day 7 that appear to be derived from one secondary
B cell precursor. All of the cDNA clones shared at least three mutations, yet each
clone had a unique overall pattern of mutation. One possibility is that the shared
mutations occurred before injection of PC-KLH, perhaps by contact with PC-
containing bacteria in the environment, and the unique mutations occurred after
deliberate immunization. Reports differ as to whethersecondary B cells can under-
go mutation after antigen stimulation. Siekevitz et al. (25) found very little muta-
tion occurring in secondary B cells stimulated during an adoptive response. In con-
trast, Berek and Milstein compared sequences obtained at primary, secondary, and
tertiary stages of the immune response and showed that the number of mutations
pergene increased from 2.4 to 5.2 to 7.7 (calculated from reference 20), respectively,
suggesting that mutation also occurs in memory B cells. The problemof determining
whetherthe mutation seen in this study was due to newlyoccurring mutation versus
mutation that took place before immunization was addressed by looking at the time
course and pattern of mutation.
The increase in frequency and number ofmutations per gene with time strongly
suggests that most ofthe mutations occurred de novo after immunization. Between2016
￿
ONSET OF SOMATIC MUTATION IN IMMUNOGLOBULIN V GENES
days 5 and 7, the frequency of mutations increased greater than twofold at a rate
of 10-3 mutations per nucleotide per generation. Assuming a constant rate of mu-
tation and cell division for the first 7 d, the results suggest that mutation started
on day 3. Thus, the mutational process appears to be most active during the early
stages of B cell activation when resting B cells are stimulated to divide and differen-
tiate into plasma cells and/or secondary cells. This developmentally regulated pro-
cess appears to coincide with B cell switching from IgM to IgG, and most likely
requires T cell factors to initiate mutation (26).
Mutation May Occur over a BriefPeriod.
￿
It would appear, however, that mutation
does not occur at a significant rate between days 7 and 13 . Although the frequency
of mutation in genes from the V 7183 and V,3660 subfamilies increased from days
7 to 13, the distribution of these later mutations suggested that the increased fre-
quency was due to selection of existing mutations rather than to generation of new
mutations. The number of mutations increased in theHVR with time and correspond-
ingly decreased in the FWR, indicating agreater degree of selection on day 13 than
7. Similarly, the R:S ratio of mutations in the HVR increased from 7.5 to 12 on
day 13, whereas the ratio of changes in the FWR was 1.8 at both time points. These
results are consistent with thehypothesis that early mutations are randomly inserted
into the gene, and subsequently selected for both accumulation and replacement
amino acids in the HVR. Furthermore, the average number of mutations per gene
did not increase beyond 3.4 on day 13 . This result is probably notdueto the inability
of the variable gene to tolerate more than three mutations since about one-third
of the mutated clones in this study had five or more mutations. Rather, it suggests
that most of the mutation occurred during the first week of the primary immune
response.
Previous reports support the idea that mutation is not a continuously active pro-
cess during clonal expansion (27, 28). In those studies, several hybridomas were in-
dependently isolated from a single mouse and shown to contain the same pattern
of mutation, implying that a mutated B cell can divide without further mutation.
We propose that mutation occurs during a short time period, about four to five cell
divisions, soon after antigen stimulation, and mutations are inserted randomly
throughout the gene. The mutational machinery is then shut off. B cells expressing
mutated antibodies are selected by antigen, and the initial random pattern shifts
to a clustered distribution of mutations and selection of replacement mutations in
the HVR. Further rounds of mutation may occur at a later time, for example, in
memory B cells restimulated after a secondary immunization.
Mutation May BeDNA StrandDirected.
￿
To gain insight into the mechanism of mu-
tation, thetypes ofnucleotide changes producing silent substitutions were analyzed.
Of 21 silent mutations found, 8 were C-T transitions on the sense strand. An excess
of C-"T mutations can result from the methylation of a cytosine residue followed
by spontaneous deamination to yield thymidine (29). The same event occurring on
the opposite strand would lead to a G-A mutation on the sense strand. However,
we observed more C-T mutations than G-"A changes, suggesting that there is a
strand preference for the incorporation of mutations. Although the sample size is
small, it is consistent with a similar study we performed on 172 silent and flanking
mutations in antibody variable genes (30), where twice as many C->T mutations
as G-A substitutions were found (p < 0.05). In contrast, among pseudogenes that
do not encode immunoglobulins, there is an equal frequency of C-T and G-Asubstitutions produced during meiosis (31). One explanation for this asymmetrical
phenomenon in variable genesis that mutationsarepreferentially incorporated into
one ofthe DNA strands. An outcome of such a mechanism is that, after subsequent
division, only one of the daughter cells is mutated whilethe other is not, preventing
loss of germline information.
Unequal Frequencies of Mutation Observed Among cDNA Clones.
￿
By day 13, the fre-
quency of mutation in the VVl gene from the VS107 subfamily was only 0.04%
compared with 0.65% mutation in genes from the V3660 and V7183 subfami-
lies. The low level of mutation in VHVI is not due to an intrinsic property of the
nucleotide sequence or protein structure that prevents mutation, since the gene has
been shown to undergo as much as 4% mutation and stillproducea functional anti-
body (2). Rather, the low frequency may be due to negative selection of mutations
that cause decreased affinity for PC. The affinity of the germline-encoded antibody
for PC appears to be better than most mutated sequences since approximately half
of secondary antibodies have no mutation (32-34). Another possibility is that PC-
specific B cells areinfrequently stimulated to mutate, perhaps by unknown interac-
tions between B and T cells. Such disparate frequencies of mutation among IgG
antibodies illustrates the need to look at more than one specificity before making
conclusions about the general frequency of mutation. As noted earlier, PC-specific
B cells comprised only a minor proportion of the immune response to PC-KLH .
B cells secreting antibodies encoded by genes in the V7183 and V3660 subfami-
lies encompassed a larger fraction of the immune response and most likely reflect
the general level of mutation. Thus, splenic B cells taken during the first week after
immunization may be agood source ofcells forelucidatingthe mechanism ofmuta-
tion at the biochemical level.
Summary
The dynamics of somatic mutation in Ig variable genes was investigated in order
to define a population ofB cells undergoing mutation. BALB/cJ mice were injected
with PC-KLH, and splenic RNA was prepared 5, 7, and 13 d later. The mRNA
was annealed to .y constant region primers to make cDNA transcripts encoding VH
genes. 103 cDNA clones corresponding to 18 different genes from the V7183,
V3660, and VS107 subfamilies were sequenced to identify mutation. VH genes
had a low level of mutation on day 5 after immunization and accumulated more
mutation by day 7 at a rate of 10-3 mutations pernucleotide per generation. How-
ever, by day 13, the number of mutations per gene did not increase, and most of
the substitutions encoded replacement amino acid changes that were clustered in
the hypervariable regions, indicating that the mutational processwas less active during
the second week and that antigen selection had occurred. The data are consistent
with adevelopmentally regulated mechanism in which mutation is activated during
thefirst week oftheprimary immune response for alimitedtime period, after which
selection acts to preserve the beneficial mutants.
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